{
    "id": "64179337690f196b51000034",
    "question": "Do machine learning-based methods outperform statistical methods for survival analysis?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to consider the context of survival analysis and the capabilities of machine learning-based methods compared to statistical methods. Survival analysis is a statistical method used to analyze the time-to-event data, such as time to recurrence or death, in various fields like medicine. Statistical methods, including Kaplan-Meier curves and Cox proportional hazards regression, have been widely used for survival analysis. Machine learning-based methods, including random forests, have also been explored for survival analysis, especially in high-dimensional data and complex datasets. However, the question of whether machine learning-based methods outperform statistical methods for survival analysis is complex and depends on the specific context and dataset. Some studies have shown that machine learning-based methods can outperform statistical methods in certain scenarios, while others have found no significant difference. The choice between machine learning-based methods and statistical methods ultimately depends on the characteristics of the dataset, the research question, and the expertise of the analyst. Therefore, a definitive answer to this question requires a more detailed analysis of the specific context and dataset in question.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_5144",
            "title": "InternalMed_Harrison",
            "content": "Random Forests analysis/ Machine learning is a collection of approaches that allow a computer to learn without being explicitly programmed. Random Forests machine learning is a machine-learning method for classification and regression that uses multiple decision trees during a training step. Rarefaction A procedure in which subsampling is used to assess whether all the diversity present in a given sample or set of samples has been observed at a given sampling depth and to extrapolate how much additional sampling would be needed to observe all the diversity Resilience A community\u2019s ability to return to its initial state after a perturbation Shotgun sequencing A method for sequencing large DNA regions or collections of regions by fragmenting DNA and sequencing the resulting smaller sections"
        },
        {
            "id": "First_Aid_Step2_227",
            "title": "First_Aid_Step2",
            "content": "Odds that a diseased person is exposed Odds ratio = Odds that a nondiseased person is exposed Odds ratio: (odds that injured staff used scissors) \u00f7 (odds that uninjured staff used scissors). Once a diagnosis has been established, it is important to be able to describe the associated prognosis. Survival analysis is used to summarize the average time from one event (e.g., presentation, diagnosis, or start of treatment) to any outcome that can occur only once during follow-up (e.g., death or recurrence of cancer). The usual method is with a Kaplan-Meier curve (see Figure 2.4-3) describing the survival (or time-to-event if the measured outcome is not death) in a cohort of patients, with the probability of survival de Probability of event creasing over time as patients die or drop out (are censored) from the study. Odds = 1 \u2212 probability of"
        },
        {
            "id": "InternalMed_Harrison_5180",
            "title": "InternalMed_Harrison",
            "content": "to nonphylogenetic methods for comparing communities, such as Euclidean distance, Jensen-Shannon divergence, or Bray-Curtis dissimilarity, which operate independent of evolutionary tree data but can make biologic patterns more difficult to identify. The taxonomic data or distance matrices can also be used as input into a range of machine-learning algorithms (such as Random Forests) that employ supervised classification to identify differences between labeled groups of samples. Supervised classification is useful for identifying differences between cases and controls but can obscure important patterns intrinsic to the data, including confounding variables such as different sequencing runs or patient populations."
        },
        {
            "id": "First_Aid_Step1_260",
            "title": "First_Aid_Step1",
            "content": "Crossover studies (subjects act as their own controls) Matching (patients with similar characteristics in both treatment and control groups) Lead-time bias Early detection is confused Early detection makes it seem Measure \u201cback-end\u201d survival with \u008f survival like survival has increased, (adjust survival according to but the disease\u2019s natural the severity of disease at the history has not changed time of diagnosis) Length-time bias Screening test detects diseases A slowly progressive cancer A randomized controlled trial with long latency period, is more likely detected by a assigning subjects to the while those with shorter screening test than a rapidly screening program or to no latency period become progressive cancer screening symptomatic earlier Mode = most common value. Least affected by outliers. Measures of Standard deviation = how much variability \u03c3 = SD; n = sample size. dispersion exists in a set of values, around the mean of Variance = (SD)2. these values. SE = \u03c3/\u221an."
        },
        {
            "id": "Gynecology_Novak_6048",
            "title": "Gynecology_Novak",
            "content": "A new approach to predicting live birth probabilities focuses on the use of machine learning or the mining of clinic-specific IVF outcomes data to provide a personalized per-cycle prognosis that pertains to the clinical scenario of each patient (381). Brie\ufb02y, a live birth prediction model was developed by boosted tree analysis of baseline clinical data, uterine response to a patient\u2019s first IVF treatment, and embryo developmental parameters, with no preselection of prognostic factors. The model predicted live birth outcomes in a subsequent IVF treatment cycle. Validation by an independent dataset and comparison with a control model that is based on chronological age alone showed that the boosted tree model was more than 1,000 times better in fitting new data and improved discrimination (i.e., the ability to discern among patients with different prognoses) by receiver\u2013operator curve analysis. Approximately 60% of patients were found to have significantly different predicted live birth"
        },
        {
            "id": "Cell_Biology_Alberts_2572",
            "title": "Cell_Biology_Alberts",
            "content": "Statistical Methods Are Critical For the Analysis of Biological Data Dynamics, differential equations, and theoretical modeling are not the be-all and end-all of mathematics. Other branches of the subject are no less important for biologists. Statistics\u2014the mathematics of probabilistic processes and noisy datasets\u2014is an inescapable part of every biologist\u2019s life. This is true in two main ways. First, imperfect measurement devices and other errors generate experimental noise in our data. Second, all cell-biological processes depend on the stochastic behavior of individual molecules, as we just discussed, and this results in biological noise in our results. How, in the face of all this noise, do we come to conclusions about the truth of hypotheses? The answer is statistical analysis, which shows how to move from one level of description to"
        },
        {
            "id": "Cell_Biology_Alberts_2574",
            "title": "Cell_Biology_Alberts",
            "content": "Statistics teaches us that the more times we repeat our measurements, the bet \u2022 Many of the tools that revolutionized ter and more refined the conclusions we can draw from them. Given many repeti-DNA technology were discovered by tions, it becomes possible to describe our data in terms of variables that summa-scientists studying basic biological rize the features that matter: the mean value of the measured variable, taken over problems that had no obvious the set of data points; the magnitude of the noise (the standard deviation of the applications. What are the best set of data points); the likely error in our estimate of the mean value (the standard strategies to ensure that such crucially important technologies will continue to error of the mean); and, for specialists, the details of the probability distribution be discovered?"
        },
        {
            "id": "First_Aid_Step2_233",
            "title": "First_Aid_Step2",
            "content": "Confounding variables reduce the internal validity of a study. years earlier may give the impression that patients are living longer with the disease. \u25a0 Length bias: Occurs when screening tests detect a disproportionate number of slowly progressive diseases but miss rapidly progressive ones, leading to overestimation of the beneft of the screen. Example: A better prognosis for patients with cancer is celebrated after implementation of a new screening program. However, this test disproportionally detects slow-growing tumors, which generally tend to be less aggressive. Even with bias reduction, unsystematic random error is unavoidable owing to chance variation in studied data. Types of errors are as follows: Type I (\u03b1) error: Defned as the probability of saying that there is a difference in treatment effects between groups when in fact there is not (i.e., a false-conclusion)."
        },
        {
            "id": "InternalMed_Harrison_29",
            "title": "InternalMed_Harrison",
            "content": "models with that of expert clinicians have documented equivalent accuracy, although the models tend to be more consistent. Thus, multivariate statistical models may be particularly helpful to less experienced clinicians. See Chap. 3 for a more thorough discussion of decision-making in clinical medicine."
        },
        {
            "id": "First_Aid_Step2_232",
            "title": "First_Aid_Step2",
            "content": "Lead-time bias: Results from earlier detection of disease, giving an appearance of prolonged survival when in fact the natural course is not altered. Example: A new and widely used screening test that detects cancer f ve Randomization minimizes bias and confounding; double-blinded studies prevent observation bias. Studies that are masked and randomized are better protected from the effects of bias, whereas observational studies are particularly susceptible to bias. Confounding variables reduce the internal validity of a study. years earlier may give the impression that patients are living longer with the disease."
        },
        {
            "id": "InternalMed_Harrison_25128",
            "title": "InternalMed_Harrison",
            "content": "PaTIENT OUTCOMES, PrOGNOSIS, aND SUrVIVaL"
        },
        {
            "id": "InternalMed_Harrison_8438",
            "title": "InternalMed_Harrison",
            "content": "Number of Risk Factors aThe corresponding survival curves for each risk category can be found in the references cited in the footnotes of Table 131-4. Abbreviations: DIPSS, Dynamic International Prognostic Scoring System; IPSS, International Prognostic Scoring System."
        },
        {
            "id": "InternalMed_Harrison_257",
            "title": "InternalMed_Harrison",
            "content": "or with Bayes\u2019 rule. However, despite this strength, prediction models are usually too complex computationally to use without a calculator or computer (although this limitation may be overcome once medicine is practiced from a fully computerized platform)."
        },
        {
            "id": "Surgery_Schwartz_13983",
            "title": "Surgery_Schwartz",
            "content": "1 (LEVEL 1*)STEP 2 (LEVEL 2*)STEP 3 (LEVEL 3*)STEP 4 (LEVEL 4*)STEP 5 (LEVEL 5)How common is the problem?Local and current random sample surveys (or censuses)Systematic review of surveys that allow matching to local circumstances**Local non-random sample**Case-series**n/aIs this diagnostic or monitoring test accurate? (Diagnosis)Systematic review of cross-sectional studies with consistently applied reference standard and blindingIndividual cross-sectional studies with consistently applied reference standard and blindingNon-consecutive studies, or studies without consistently applied reference standards**Case-control studies, or \u201cpoor or non-independent reference standard**Mechanism-based reasoningWhat will happen if we do not add a therapy? (Prognosis)Systematic review of inception cohort studiesInception cohort studiesCohort study or control arm of randomized trial*Case-series or case-control studies, or poor quality prognostic cohort study**n/aDoes this intervention help? (Treatment"
        },
        {
            "id": "InternalMed_Harrison_256",
            "title": "InternalMed_Harrison",
            "content": "Bayes\u2019 rule, while illustrative as presented above, provides an unrealistically simple solution to most problems a clinician faces. Predictions based on multivariable statistical models, however, can more accurately address these more complex problems by accounting for specific patient characteristics. In particular, these models explicitly account for multiple possibly overlapping pieces of patient-specific information and assign a relative weight to each on the basis of its unique contribution to the prediction in question. For example, a logistic regression model to predict the probability of CAD considers all the relevant independent factors from the clinical examination and diagnostic testing and their significance instead of the limited data that clinicians can manage in their heads or with Bayes\u2019 rule. However, despite this strength, prediction models are usually too complex computationally to use without a calculator or computer (although this limitation may be overcome once"
        },
        {
            "id": "InternalMed_Harrison_259",
            "title": "InternalMed_Harrison",
            "content": "Over the last 40 years, many attempts have been made to develop computer systems to aid clinical decision-making and patient management. Conceptually attractive because computers offer ready access to the vast information available to today\u2019s physicians, they may also support management decisions by making accurate predictions of outcome, simulating the whole decision process, or providing algorithmic guidance. Computer-based predictions using Bayesian or statistical regression models inform a clinical decision but do not actually reach a \u201cconclusion\u201d or \u201crecommendation.\u201d Artificial intelligence systems attempt to simulate or replace human reasoning with a computer-based analogue. To date, such approaches have achieved only limited success. Reminder or protocol-directed systems do not make predictions but use existing algorithms, such as guidelines, to guide clinical practice. In general, however, decision support systems have had little impact on practice. Reminder systems, although"
        },
        {
            "id": "InternalMed_Harrison_28",
            "title": "InternalMed_Harrison",
            "content": "battery of diagnostic tests complements the history and the physical examination. The accuracy of a particular test is ascertained by determining its sensitivity (true-positive rate) and specificity (true-negative rate) as well as the predictive value of a positive and a negative result. Bayes\u2019 theorem uses information on a test\u2019s sensitivity and specificity, in conjunction with the pretest probability of a diagnosis, to determine mathematically the posttest probability of the diagnosis. More complex clinical problems can be approached with multivariate statistical models, which generate highly accurate information even when multiple factors are acting individually or together to affect disease risk, progression, or response to treatment. Studies comparing the performance of statistical models with that of expert clinicians have documented equivalent accuracy, although the models tend to be more consistent. Thus, multivariate statistical models may be particularly helpful to less"
        },
        {
            "id": "Surgery_Schwartz_13955",
            "title": "Surgery_Schwartz",
            "content": "tools are aggregated and presented in order to inform a surgeon how to keep abreast with current developments in practice.WHAT IS EVIDENCE-BASED MEDICINE?For centuries, the practice of medicine was guided primarily by anecdotal experience, often based on rationales that did not arise from a rigorous scientific process and sustained by the fundamental barriers associated with being able to learn from one\u2019s experience (e.g., cognitive bias). For example, treatments such as bloodletting and purging were based on ostensible prin-ciples of bodily humors originating from the Ancient Greeks, and persisted well into the 18th century despite repeated disas-trous outcomes. To a great degree, the goal of the Scientific Method, through its emphasis on skepticism and falsifiability, is predicated upon overriding observational/experiential bias by the application of rigorous methodology statistical analysis. The dangers of bias were recognized at the dawn of the Scien-tific Era, and continue to"
        },
        {
            "id": "InternalMed_Harrison_5984",
            "title": "InternalMed_Harrison",
            "content": "test has a better cause-specific mortality rate than the control group. Studies showing a reduction in the incidence of advanced-stage disease, improved survival, or a stage shift are weaker (and possibly misleading) evidence of benefit. These latter criteria are early indicators but not sufficient to establish the value of a screening test."
        },
        {
            "id": "Surgery_Schwartz_13970",
            "title": "Surgery_Schwartz",
            "content": "rare in the surgical literature, the application of EBM to surgery requires increased familiarity with the types of alternative studies available, with their relative strengths and weaknesses. These types are listed below:\u2022 Meta-analysis: A meta-analysis is a technique to combine similarly published data in order to increase the overall 2statistical power compared to each study individually. The amount of interstudy heterogeneity (methods, study popula-tion, endpoints, etc.) should be limited to allow for the gen-eration of informative conclusions. The pooling of similar studies enables researchers to generate a new statistical con-clusion based on a substantially larger sample size. These approaches, though useful, have their limitations: the inclu-sion of inappropriate studies and the mislabeling of a meta-analysis leading to inaccurate conclusions. Attention should be directed toward this type of evidence when clinical guide-lines do not exist.\u2022 Systematic Review: Like"
        },
        {
            "id": "Cell_Biology_Alberts_5724",
            "title": "Cell_Biology_Alberts",
            "content": "lung cancer mortality, cumulative risk (%) Figure Q20\u20131 Cumulative risk of lung cancer mortality for nonsmokers, smokers, and former smokers (Problem 20\u20136). Cumulative risk is the running total of deaths, as a percentage, for each group. Thus, for continuing smokers, 1% died of lung cancer risk of 5%); and 11% more cumulative risk of 16%). 20\u20136 Mortality due to lung cancer was followed in groups of males in the United Kingdom for 50 years. Figure Q20\u20131 shows the cumulative risk of dying from lung cancer as a function of age and smoking habits for four groups of males: those who never smoked, those who stopped at age 30, those who stopped at age 50, and those who continued to smoke. These data show clearly that individuals can substantially reduce their cumulative risk of dying from lung cancer by stopping smoking. What do you suppose is the biological basis for this observation?"
        },
        {
            "id": "InternalMed_Harrison_258",
            "title": "InternalMed_Harrison",
            "content": "To date, only a handful of prediction models have been validated properly (for example, Wells criteria for pulmonary embolism) (Table 3-2). The importance of independent validation in a population separate from the one used to develop the model cannot be overstated. An unvalidated prediction model should be viewed with the skepticism appropriate for any new drug or medical device that has not had rigorous clinical trial testing. When statistical models have been compared directly with expert clinicians, they have been found to be more consistent, as would be expected, but not significantly more accurate. Their biggest promise, then, may be in helping less-experienced clinicians identify critical discriminating patient characteristics and become more accurate in their predictions."
        },
        {
            "id": "First_Aid_Step2_228",
            "title": "First_Aid_Step2",
            "content": "Probability of event creasing over time as patients die or drop out (are censored) from the study. Odds = 1 \u2212 probability of Studies are typically used to judge the best treatment for a disease. Although the gold standard for such evaluation is a randomized, double-masked controlled trial, other types of studies may be used as well (e.g., an observational F IGU R E 2.4-3. Example of a Kaplan-Meier curve. study, in which the exposure in question is a therapeutic intervention). In descending order of quality, published studies regarding treatment options include meta-analyses, randomized controlled trials, and case series/case reports."
        },
        {
            "id": "InternalMed_Harrison_6707",
            "title": "InternalMed_Harrison",
            "content": "an effect on survival), length-time bias (indolent cancers are detected on screening and may not affect survival, whereas aggressive cancers are likely to cause symptoms earlier in patients and are less likely to be detected), and overdiagnosis (diagnosing cancers so slow growing that they are unlikely to cause the death of the patient) (Chap. 100)."
        },
        {
            "id": "InternalMed_Harrison_7718",
            "title": "InternalMed_Harrison",
            "content": "mRNA-or microRNA-based tissue of origin molecular profiling assays have been studied in prospective and retrospective CUP trials. Most of the CUP studies have evaluated assay performance, although the challenge with validating the accuracy of an assay for CUP is that, by definition, the primary cancer diagnosis cannot be verified. Thus, current estimates of tissue of origin test accuracy have relied on indirect metrics including comparison with IHC, clinical presentation, and appearance of latent primaries. Using these measures, the assays suggest a plausible primary in ~70% of patients studied. The only out-comes-based study is a single-arm study reporting a median survival of 12.5 months for patients who received assay-directed site-specific therapy. Firm conclusions of therapeutic impact cannot be drawn from this study given the nonrandomized design, statistical biases, confounding variables including use of subsequent lines of (empiric) therapy, and the heterogeneity of the CUP"
        },
        {
            "id": "InternalMed_Harrison_7428",
            "title": "InternalMed_Harrison",
            "content": "success or failure. In these situations, nomograms and predictive models can only go so far. Exactly what probability of success or failure would lead a physician to recommend and a patient to seek alternative approaches is controversial. As an example, it may be appropriate to recommend radical surgery for a younger patient with a low probability of cure. Nomograms are being refined continually to incorporate additional clinical parameters, biologic determinants, and year of treatment, which can also affect outcomes, making treatment decisions a dynamic process."
        },
        {
            "id": "Surgery_Schwartz_14026",
            "title": "Surgery_Schwartz",
            "content": "under 100 in 2005 to nearly 600 in 2015.27 The most important consideration when evaluating this type of trial is the prespecified margin of noninferiority, a value that is largely arbitrary in the literature.28USE AND MISUSE OF STATISTICAL SIGNIFICANCEThe use of statistical methods is central to the scientific process; it is only through statistics that the problem of induction29 can be addressed. While this chapter is not intended to be 6a comprehensive description of statistical methods, understand-ing the appropriate application of statistical tools is critical to being able to assess the conclusions presented in the literature, and therefore we present a summary of those statistical terms that are most germane to being able to interpret a clinical study.Type I and Type II ErrorsBy necessity, statistical testing requires declaration of a null hypothesis, usually corresponding to the \u201cdefault\u201d state (i.e., no difference or the patient is healthy). The alternative hypothesis would"
        },
        {
            "id": "Pharmacology_Katzung_112",
            "title": "Pharmacology_Katzung",
            "content": "Many phase 2 and phase 3 studies attempt to measure a new drug\u2019s \u201cnoninferiority\u201d to the placebo or a standard treatment. Interpretation of the results may be difficult because of unexpected confounding variables, loss of subjects from some groups, or realization that results differ markedly between certain subgroups within the active treatment (new drug) group. Older statistical methods for evaluating drug trials often fail to provide definitive answers when these problems arise. Therefore, new \u201cadaptive\u201d statistical methods are under development that allow changes in the study design when interim data evaluation indicates the need. Preliminary results with such methods suggest that they may allow decisions regarding superiority as well as noninferiority, shortening of trial duration, discovery of new therapeutic benefits, and more reliable conclusions regarding the results (see Bhatt & Mehta, 2016)."
        },
        {
            "id": "InternalMed_Harrison_6070",
            "title": "InternalMed_Harrison",
            "content": "profiling of tumors, which has suggested general methods for distinguishing tumors of various biologic behaviors (molecular classification), elucidating pathways relevant to the development of tumors, and identifying molecular targets for the detection and therapy of cancer. The first practical applications of this technology have suggested that global gene expression profiling can provide prognostic information not evident from other clinical or laboratory tests. The Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) is a searchable online repository for expression profiling data."
        },
        {
            "id": "InternalMed_Harrison_278",
            "title": "InternalMed_Harrison",
            "content": "The Greek prefix meta signifies something at a later or higher stage of development. Meta-analysis is research that combines and summarizes the available evidence quantitatively. Although occasionally used to examine nonrandomized studies, meta-analysis is used most typically to summarize all randomized trials examining a particular therapy. Ideally, unpublished trials should be identified and included to avoid publication bias (i.e., missing \u201cnegative\u201d trials that may not be published). Furthermore, the best meta-analyses obtain and analyze individual patient-level data from all trials rather than working only the summary data in published reports of each trial. Nonetheless, not all published meta-analyses yield reliable evidence for a particular problem, so their methodology should be scrutinized carefully to ensure proper study design and analysis. The results of a well-done meta-analysis are likely to be most persuasive if they include at least several large-scale, properly"
        },
        {
            "id": "InternalMed_Harrison_6873",
            "title": "InternalMed_Harrison",
            "content": "a potential exception. Detection of breast cancer cells either in the circulation or bone marrow is associated with an increased relapse rate. The most exciting development in this area is the use of gene expression arrays to analyze patterns of tumor gene expression. Several groups have independently defined gene sets that reliably predict disease-free and overall survival far more accu"
        },
        {
            "id": "InternalMed_Harrison_8586",
            "title": "InternalMed_Harrison",
            "content": "Pretreatment prognostic factors and prognostic models have lost much of their clinical relevance to define prognosis and to select different therapies. However TKI-associated therapeutic responses have gained major clinical relevance and dictate appropriate and careful monitoring of patients to optimize their treatment."
        }
    ],
    "scores": [
        0.03540538876550023,
        0.03194948706424117,
        0.026952440877300827,
        0.025921316781383152,
        0.025902014164550097,
        0.024635939058306508,
        0.024615611902078158,
        0.02378073412401222,
        0.023177715467303114,
        0.023096098555889594,
        0.022175428713345085,
        0.02198834037654423,
        0.02192083374140103,
        0.021350055173584584,
        0.018605053651782624,
        0.018329427519250083,
        0.01628327733264409,
        0.01621417797888386,
        0.016133162612035852,
        0.015881577370250508,
        0.015674908316573997,
        0.01558331312151346,
        0.01508295625942685,
        0.014803921568627452,
        0.01462251655629139,
        0.014320521107851425,
        0.014270407169296707,
        0.014082462253193961,
        0.013894919669995658,
        0.013704416388980147,
        0.013502454991816694,
        0.013432323405716248
    ]
}